Premier Alternatives

PanTher Therapeutics

Austin, TX · Founded 2014 · Privately Held (backing)

Developer of a cancer treatment technology designed to deliver therapeutics directly to the tumor site. PanTher Therapeutics is based in Austin, TX and was founded in 2014. Its last reported valuation was $10.9 million in Jun 2022. It has raised $15.5 million across 2 recorded rounds; the latest was a $3 million seed round in Mar 2025.

Last reported valuation
$10.9M
Oct 2026
Priced at
—
Total raised
$15.5M
Last round
Seed Round
Mar 2025

PanTher Therapeutics key facts

as of Oct 2026
  • Developer of a cancer treatment technology designed to deliver therapeutics directly to the tumor site.
  • PanTher Therapeutics is valued at approximately $10.9M as of Oct 2026 (last reported valuation).
  • It has raised $15.5M across 2 recorded rounds; the latest was Seed Round ($3.0M) in Mar 2025.
  • Notable investors include MassChallenge, MedTech Innovator, Springboard Enterprises, Keiretsu Forum, Johnson & Johnson Innovation - JLABS — 18 tracked in total.
  • PanTher Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently Apr 2025 ($3.0M sold to 26 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$10.9M

PanTher Therapeutics's last reported valuation, Jun 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of PanTher Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch PanTher Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

PanTher Therapeutics funding rounds

2 rounds
Mar 2025Seed Round$3.0MSEC filing▮
Nov 2023Seed Round$2.7MSEC filing▮
Full funding history →

PanTher Therapeutics valuation

PanTher Therapeutics's last reported valuation was $10.9 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has PanTher Therapeutics raised?

PanTher Therapeutics has raised $15.5 million in total; 2 of its rounds are on record. The largest on record was a $3 million seed round in Mar 2025.

PanTher Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Apr 2025 ($3 million sold to 26 investors).

PanTher Therapeutics investors

18 investors are on record for PanTher Therapeutics, including MassChallenge, MedTech Innovator, Springboard Enterprises and Keiretsu Forum. The seed round in Mar 2025 drew 26 investors.

About PanTher Therapeutics

Developer of a cancer treatment technology designed to deliver therapeutics directly to the tumor site. The company's technology allows oncologists to treat patients with cancer by improving a drug's full potential through direct, sustained treatment, enabling medical professionals to provide targeted, effective treatments and improve clinical outcomes.

Sector
Healthcare
HQ
Austin, TX, United States
Founded
2014
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.